Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Biotechnology Progress|February 4, 2015
Challenges with afucosylation content in antibody-based drugs: Guidance provided by mathematical modelingPeter L Zhan, John D ChungBiotechnology Progress|December 27, 2016
General solutions to decompose heterogeneous compositions using antibody afucosylation as a model systemJohn D Chung, Peter L ZhanJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 26, 2019
Stereotactic radiosurgery and fractionated radiotherapy for spinal arteriovenous malformations - A systematic review of the literaturePeter L Zhan, Babak S Jahromi, Tim J Kruser, et al.The Journal of Surgical Research|November 30, 2024
Practice Patterns and Trends in the Surgical Management of Mismatch Repair Deficient Colon CancerPrincy Gupta, Peter L Zhan, Ira Leeds, et al.The Journal of Thoracic and Cardiovascular Surgery|June 26, 2024
Surgical and endoscopic management of clinical T1b esophageal cancerOluwaseun F Ayoade, Maureen E Canavan, Will P De Santis, et al.Journal of Thoracic Disease|March 20, 2024
Perioperative morbidity and 3-year survival in non-intubated thoracoscopic surgery: a propensity matched analysisBrooks V Udelsman, Anna Jang, Ashok Muniappan, et al.The Annals of Thoracic Surgery|June 30, 2025
Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database AnalysisPeter L Zhan, Maureen E Canavan, Justin M Bader, et al.Clinical Lung Cancer|October 27, 2024
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on OsimertinibNathaniel D Robinson, Maureen E Canavan, Peter L Zhan, et al.The Journal of Thoracic and Cardiovascular Surgery|July 27, 2023
Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgeryBrooks V Udelsman, Maureen E Canavan, Peter L Zhan, et al.JTO Clinical and Research Reports|November 29, 2022
Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal CancerPeter L Zhan, Maureen E Canavan, Theresa Ermer, et al.Pageof 2